Evidence map›Paper›PMID 42334537›Full record

ReviewAdvances in experimental medicine and biology2026

Supramolecular Assemblies Drive Activation of Inflammasomes.

Zhangfei Shen, Chen Wang, Tian-Min Fu

Abstract readReview
PubMed Publisher
In one paragraph

Review in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zhangfei Shen *Department of Pathology, UMass Chan Medical School, Worcester, MA, USA.
Chen Wang *Department of Pathology, UMass Chan Medical School, Worcester, MA, USA.
Tian-Min FuDepartment of Pathology, UMass Chan Medical School, Worcester, MA, USA. Tianmin.Fu@umassmed.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammasomes are large cytosolic protein complexes that detect and respond to pathogenic and endogenous danger signals, triggering critical innate immune defenses. This chapter outlines the structural and mechanistic features of canonical inflammasomes, focusing on NLRP1, NLRP3, NAIP-NLRC4, NLRP6, and AIM2. Canonical inflammasomes often comprise a sensor protein (e.g., an NLR or AIM2), the adaptor ASC, and pro-caspase-1, which are assembled upon ligand binding. NLR sensors detect diverse signals, ranging from bacterial toxins and lipopolysaccharides to crystals and ATP, while AIM2 recognizes cytosolic double-stranded DNA. Once activated, these inflammasomes facilitate caspase-1-dependent maturation of IL-1β and IL-18, as well as cleavage of gasdermin D, culminating in pyroptotic cell death and pro-inflammatory cytokine release. Structural insights reveal that inflammasome activation transitions from an autoinhibited state to filamentous or ring-shaped supramolecular assemblies. Despite ligand diversity and varying activation pathways, inflammasomes share unifying principles in their oligomerization-driven activation. Elucidating these mechanisms advances our understanding of how cells mount rapid, robust immune responses and paves the way for developing therapeutic interventions in inflammatory and infectious diseases.

Indexed as

Immunity, InnateInflammasomesAnimalsDNA-Binding ProteinsHumansInnate Immunity RecognitionSignal TransductionDNA-Binding ProteinsInflammasomesAIM2CaspaseDAMPGSDMDInflammasomeInnate immunityNAIPNLRC4NLR familyNLRP1NLRP3NLRP6Noncanonical inflammasomePAMPPyroptosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.